SDC1 is a critical transmembrane proteoglycan in breast cancer
Abstract There has been an increasing incidence of breast cancer around the world in recent years. As a burgeoning model of diagnosis and treatment, precision medicine has become a new trend in breast cancer management. Dysregulated glycometabolism is well established as a tumor feature. SDC1 is a g...
Saved in:
| Main Authors: | Yingying Mei, Lantao Zhao, Na Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | World Journal of Surgical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12957-025-03840-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of SDC2 and SEPT9 methylation tests in the early detection of colorectal cancer: a systematic review and meta-analysis
by: Jie Zhang, et al.
Published: (2024-12-01) -
Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts
by: Zhiheng Lin, et al.
Published: (2025-07-01) -
Tumor-associated neutrophils in breast cancer: an angel or a devil?
by: Siyuan Wen, et al.
Published: (2025-06-01) -
The Potential Role of C4 MYH11+ Fibroblasts and the MDK-SDC2 Ligand-Receptor Pair in Lung Adenocarcinoma: Implications for Prognosis and Therapeutic Strategies
by: Hongling Jia, et al.
Published: (2025-05-01) -
Analysis of the effect of fecal SDC2, ADHFE1 and PPP2R5C gene methylation test for screening colorectal cancer in the Otog Front Banner
by: Fan Zeng, et al.
Published: (2025-04-01)